Health Behaviour and Readiness to Change After Myocardial Infarction: A Cross-sectional Survey

NCT07785921 | Not Yet Recruiting

• 2 other identifiers: 26-12963-BOHabilitation Scholarship
• Study Type: observational
• Target: 143
• Locations: 1 country
• Sites: 1

Brief Summary

This study investigates health behaviour and readiness for lifestyle change in patients who recently had a heart attack (myocardical infarction) treated with stenting (PTCA). Despite successful acute treatment, many patients remain at increased risk of a second heart atttack because lifestyle changes are not consistently maintained. Participants who had a heart attack within the past 6 months will complete standardized questionnaires on readiness to change, quality of life, anxiety/depression, and physical functioning, plus a free-text section on personal barriers to change. Findings will characterize this population and inform a future lifestyle intervention trial

Conditions

Cardiovascular (CV) Risk; Heart Attack Patients

Keywords

secondary prevention; prevention; heart attack; lifestyle modification; cardiovascular disease

Outcome Measures

Primary Outcomes (1)

• PIAC (Perception, Intention and Ability to Change) Scale

  Readiness and ability to change health-related behavior, habits and living conditions, assessed using the PIAC questionnaire, a validated 9 item instrument covering awareness of negative health behaviors, intention to change and implementation of change strategies. Higher scores indicate a better awareness and intention to change.

  Single assessement at study enrollment

Secondary Outcomes (3)

• SF-36 (Short-form 36 Health Survey)

  Single assessement at study enrollment.

• HADS (Hospital Anxiety and Depression Scale)

  Single assessement at study enrollment.

• KCCQ-23 (Kansas City Cardiomyopathy Questionnaire)

  Single assessement at study enrollment.

Study Arms (1)

Post-Myocardial Infarction Patients

Patients aged 18 years or older who experienced a myocardical infarction within the past 6 months, treated with percutaneous transluminal coronary angioplasty (PTCA), and recruited during ther routine post-discharge follow-up visit at the Lipidambulanz (lipid outpatient clinic), Westdeutsches Herz- und Gefäßzentrum, University Hospital Essen. Participants complete a one-time set of questionnaires.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients from the catchment area of the Westdeutsches Herz- und Gefäßzentrum, University Hospital Essen, treated for acute myocardial infarction with PTCA. Recruitment and eligibility screening take place during the routine post-discharge follow-up visit at the Lipidambulanz, within approx. 3 months. after the index event. creening is performed by the treating physician within the existing doctor-patient relationshop, without recording study-specifix personal data. Eligible patients are approached in person by a stdy physician and enrolled only after written informed consent.

You may qualify if:

• age over 18 years
• myocardial infarction within past 6 months
• PTCA treatment

You may not qualify if:

• Age under 18
• history of multiple myocardial infactionrs
• myocardial infarction more than 6 months prior
• myocardial infarction not treated by PTCA
• absence of informed consent
• severe cognitive impairment precluding data collection

Sponsors & Collaborators

• Kliniken Essen-Mitte: lead
• Universitätsklinikum Essen: collaborator

Study Sites (1)

University Hospital Essen

Essen, North Rhine-Westphalia, Germany

Location

Related Publications (8)

• Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol. 2000 Apr;35(5):1245-55. doi: 10.1016/s0735-1097(00)00531-3.

  PMID: 10758967 BACKGROUND

• Endler NS, Hunt JM. Generalizability of contributions from sources of variance in the S-R inventories of anxiousness. J Pers. 1969 Mar;37(1):1-24. doi: 10.1111/j.1467-6494.1969.tb01728.x. No abstract available.

  PMID: 5778965 BACKGROUND

• Chen JJ, Anand SK, Porter PJ. Infectious mononucleosis with thrombocytopenic purpura. Pediatrics. 1968 Feb;41(2):526-8. No abstract available.

  PMID: 5688970 BACKGROUND

• Lehmann N, Paul A, Moebus S, Budde T, Dobos GJ, Michalsen A. Effects of lifestyle modification on coronary artery calcium progression and prognostic factors in coronary patients--3-year results of the randomized SAFE-LIFE trial. Atherosclerosis. 2011 Dec;219(2):630-6. doi: 10.1016/j.atherosclerosis.2011.08.050. Epub 2011 Sep 6.

  PMID: 21944697 BACKGROUND

• Sanchez Angulo JI, Cuesta Lopez MJ, Zapata Lopez A, Perez Cortes S. [HIV infection and porphyria cutanea tarda]. Enferm Infecc Microbiol Clin. 1997 Aug-Sep;15(7):392-3. No abstract available. Spanish.

  PMID: 9410059 BACKGROUND

• Ornish D, Scherwitz LW, Billings JH, Brown SE, Gould KL, Merritt TA, Sparler S, Armstrong WT, Ports TA, Kirkeeide RL, Hogeboom C, Brand RJ. Intensive lifestyle changes for reversal of coronary heart disease. JAMA. 1998 Dec 16;280(23):2001-7. doi: 10.1001/jama.280.23.2001.

  PMID: 9863851 BACKGROUND

• Nguyen XT, Li Y, Wang DD, Whitbourne SB, Houghton SC, Hu FB, Willett WC, Sun YV, Djousse L, Gaziano JM, Cho K, Wilson PW; VA Million Veteran Program. Impact of 8 lifestyle factors on mortality and life expectancy among United States veterans: The Million Veteran Program. Am J Clin Nutr. 2024 Jan;119(1):127-135. doi: 10.1016/j.ajcnut.2023.10.032. Epub 2023 Dec 7.

  PMID: 38065710 BACKGROUND

• Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004 Sep 11-17;364(9438):937-52. doi: 10.1016/S0140-6736(04)17018-9.

  PMID: 15364185 BACKGROUND

MeSH Terms

Conditions

Myocardial Infarction; Cardiovascular Diseases

Condition Hierarchy (Ancestors)

Myocardial Ischemia; Heart Diseases; Vascular Diseases; Infarction; Ischemia; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Necrosis

Study Officials

• Wiebke Kohl, Dr.med

  Center for Integrative Medicine and Planetary Health, University Hospital Essen

  PRINCIPAL INVESTIGATOR

• Gustav Dobos, Prof. Dr. med.

  Center for Integrative Medicine and Planetary Health, University Hospital Essen

  STUDY DIRECTOR

Central Study Contacts

Wiebke K Kohl-Heckl, Dr.med.

CONTACT

004920117425012; w.kohl-heckl@kem-med.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Dr.med.

Study Record Dates

• First Submitted: August 21, 2026
• First Posted: August 25, 2026
• Study Start (Estimated): September 15, 2026
• Primary Completion (Estimated): March 30, 2027
• Study Completion (Estimated): September 30, 2028
• Last Updated: August 25, 2026

Record last verified: 2026-08

Data Sharing

• IPD Sharing: Will not share

Locations

DE (1)